GSK Settles Nearly All State Zantac Cases For Up To $2.2B
By Celeste Bott · October 9, 2024, 1:24 PM EDT
GSK said Wednesday that it will pay up to $2.2 billion to settle roughly 80,000 state court cases claiming Zantac heartburn medication or the generic ranitidine caused them to develop cancer....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login